Slate Path Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$71.4M |
| 2 |
TripAdvisor
TRIP
|
+$37.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$27.3M |
| 4 |
PayPal
PYPL
|
+$22.4M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zillow
Z
|
+$56M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$21.3M |
| 3 |
Oneok
OKE
|
+$19.9M |
| 4 |
Williams Companies
WMB
|
+$17M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.02% |
| 2 | Healthcare | 13.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 8.13% |
| 5 | Energy | 6.64% |
Similar funds
Slate Path Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Slate Path Capital held 16 positions worth $1.29B, up 39% from $924M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Slate Path Capital deployed $345M of net new capital in Q1 2016, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 430,000 shares worth $18.2M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was TIME WARNER CABLE INC NEW COM STK, an estimated $14.2M trimmed.
- Slate Path Capital's largest Q1 2016 buy was IVERIC bio, Inc. Common Stock: 430,000 shares worth $18.2M.
- Slate Path Capital added most to VanEck Gold Miners ETF in Q1 2016, an estimated $71.4M increase.
- Slate Path Capital's biggest Q1 2016 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $14.2M.
- Slate Path Capital fully exited Zillow in Q1 2016, selling an estimated $56M.
- Slate Path Capital's ten largest holdings make up 100% of its $1.29B portfolio in Q1 2016.
- Slate Path Capital opened 2 new positions and closed 6 in Q1 2016.
- Slate Path Capital's portfolio value rose 39% quarter-over-quarter to $1.29B.
Based on Slate Path Capital's 13F filing for Q1 2016, filed 16 May 2016.